Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 72.50
Bid: 60.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 25.00 (41.667%)
Open: 72.50
High: 76.00
Low: 76.00
Prev. Close: 76.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Jul 2023 07:00

RNS Number : 1647H
Biome Technologies PLC
26 July 2023
 

 

26 July 2023

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited trading update for the quarter ended 30 June 2023. The Company's unaudited interim results for the six months ended 30 June 2023 ("2023 H1") are expected to be announced on 27 September 2023.

 

Group revenues for 2023 H1 were £3.6m (2022 H1: £2.4m) an increase of £1.2m or 47% on 2022 H1. This has been driven by continued robustness of demand in the Bioplastics division from existing and new customers in North America, both for flexible film and filtration mesh applications.

 

The Group's trading during 2023 Q2 continued in line with management expectations with revenue for 2023 Q2 £1.7m, 24% ahead of the same period last year (2022 Q2: £1.4m), although lower than 2023 Q1 (2023 Q1: £1.9m).

 

The Group had a cash balance as at 30 June 2023 of £0.93m (30 June 2022: £0.65m) and had 2026 convertible loan notes outstanding of £0.85m and no bank debt.

 

Bioplastics Division

 

The division's revenues for 2023 H1 were £3.0m, a 50% increase on 2022 H1 (2022 H1: £2m). 2023 Q2 revenues were £1.4m, 11% behind 2023 Q1 (2023 Q1: £1.6m) but 37% ahead of 2022 Q2 last year (2022 Q2: £1.0m).

 

The Bioplastics division continues to see a high level of interest in its products in North America across a wider variety of applications than has been seen traditionally. Management expects demand for the division's products in 2023 H2 to continue and reach similar levels to that experienced in the 2023 Q2, with further growth linked to product launches (the timing of which remain uncertain as referenced in previous trading statements).

 

RF Technologies Division

 

Revenues in the RF Technologies division for the 2023 Q2 were £0.3m, consistent with 2022 Q2 (£0.3m) and in line with 2023 Q1 (2023 Q1: £0.3m). Revenues for 2023 H1 were £0.5m representing an increase of 25% compared to 2022 H1 (2022 H1: £0.4m).

 

On 22 June 2023, the division announced a significant new contract win with a revenue value of £452,000 for the supply of a novel induction furnace system to a global manufacturer of scientific glass products. As highlighted in that announcement, specific revenue timing was dependent on the availability of key components that were to be identified during the design phase. Due to issues with the availability of certain of these components, it is now anticipated that all revenue associated with this contract will be recognised in 2024.

 

The division continues to be in discussions with a number of potential customers regarding contracts that would have revenue recognition potential for 2023 H2 and beyond.

 

Management is pleased with the novel market sectors in which the division is building a pipeline of new and potential new business and the scale of some of the opportunities in this pipeline. We remain cautious on the precise timing of revenue recognition, given much of this work requires considerable new collaborative design with customers and draws on components from supply chains that remain somewhat uncertain.

 

Group Outlook

 

The Board is pleased that both divisions are performing well. The Bioplastics division continues to outperform substantially against last year and, despite the expected timing delay in being able to recognise revenue for its newly won large contract, the RF Technologies division is confident of winning further business of a similar nature.

 

Whilst we continue to be cautious in light of the current macroeconomic environment and despite the changes in the sales mix between the divisions, management's outlook for the overall performance of Biome for 2023 remains unchanged and in-line with current market expectations.

 

-Ends-

 

For further information please contact:

Biome Technologies plc

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner/Tony Quirke (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics and RF Technologies.

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

 

RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics and other industrial markets.

 

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKPBNABKDBOB
Date   Source Headline
20th Jan 20177:00 amRNSPre-close Trading Statement
18th Jan 20177:00 amRNSSettlement Agreement
2nd Nov 20167:00 amRNSTrading Update
31st Aug 20167:00 amRNSHalf-year Report
27th Jun 20167:00 amRNSTrading Update
25th Apr 201612:34 pmRNSResult of Annual General Meeting
25th Apr 20167:00 amRNSTrading Update
1st Apr 201610:42 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 20167:00 amRNSFinal Results
26th Jan 20167:00 amRNSPre-close Trading Statement
3rd Nov 20157:00 amRNSTrading Statement
2nd Sep 20157:00 amRNSInterim Results
23rd Jul 20157:00 amRNSTrading Update
19th Jun 20159:00 amRNSNew Contract
27th Apr 20154:46 pmRNSResult of AGM
27th Apr 20157:00 amRNSTrading Update
27th Mar 20153:43 pmRNSNotice of Annual General Meeting
25th Mar 20157:00 amRNSPreliminary Results
19th Feb 20153:26 pmRNSFunding Award
29th Jan 20157:00 amRNSOperational Update
22nd Jan 20157:00 amRNSPre-close Trading Statement
21st Jan 20154:35 pmRNSHolding(s) in Company
11th Dec 201410:11 amRNSChange of Adviser
14th Nov 20149:58 amRNSHolding(s) in Company
4th Nov 20147:00 amRNSTrading Update
3rd Sep 20147:00 amRNSInterim Results
12th Aug 20149:36 amRNSHolding(s) in Company
31st Jul 20147:00 amRNSContract progress for RF Technologies Business
24th Jul 20143:28 pmRNSTrading Update
6th Jun 20143:56 pmRNSHolding(s) in Company
7th May 20147:00 amRNSEMI Share Option Plan
23rd Apr 201412:26 pmRNSResult of AGM and Appointment of Director
23rd Apr 20147:00 amRNSTrading Update
31st Mar 20147:00 amRNSUpdated Corporate Presentation
28th Mar 20147:02 amRNSPosting of Notice of AGM & Annual Report
27th Mar 20147:00 amRNSPreliminary Results
24th Mar 201411:43 amRNSContract for Stanelco RF Technologies Division
19th Feb 20149:01 amRNSHolding(s) in Company
24th Jan 20147:00 amRNSPre-close Trading Statement
4th Dec 20133:37 pmRNSIssue of Shares to Director
28th Nov 20131:30 pmRNSDirector/PDMR Shareholding
27th Nov 20137:00 amRNSHolding(s) in Company
4th Nov 20137:00 amRNSTrading Update
31st Oct 201312:27 pmRNSTotal Voting Rights
2nd Oct 201312:47 pmRNSIssue of Shares to a Director
27th Sep 20138:51 amRNSTR-1: Notification of Major Interest in Shares
25th Sep 201312:33 pmRNSResult of General Meeting
2nd Sep 20137:10 amRNSNotice of General Meeting
2nd Sep 20137:00 amRNSInterim Results
26th Jul 20137:00 amRNSPurchase of Shares following Consolidation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.